← SynDRA
SYN1611795
SynDRA canonical compound SYN1611795 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | SCN1A | SCN3A |
|---|
| Mechanism of action | sodium channel blocker |
|---|
All known targets
Mechanisms of action (all sources)
- SCN1A MODULATOR
- SCN3A MODULATOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Cross-references
Synonyms
- RefChem:441517
- ICA 121431
- 2,2-DIPHENYL-N-[4-(THIAZOL-2-YLSULFAMOYL)-PHENYL]-ACETAMIDE
- MFCD00992334
- C23H19N3O3S2
- Oprea1_549338
- Oprea1_750763
- AH-034/07293036
- orb1299908
- SCHEMBL15113469
- GTPL14012
- GLXC-90313
- NMA25451
- BDBM50118516
- EBC-44159
- HB1017
- ICA121431
- STK081225
- AKOS000487880
- ICA-121431?
- NCGC00379252-02
- DA-74390
- HY-16787
- MS-28143
- T7336
- F16058
- EN300-1212519
- F808100
- SR-01000004656
- SR-01000004656-1
- Z30538253
- F0012-0842
- 2,2-diphenyl-N-[4-(thiazol-2-ylsulfamoyl)phenyl]acetamide
- 8DE
Look up SYN1611795 in the interactive SynDRA portal →